|
V.SBM
|
A personal comment/analysis from me: https://www.spekunauten.de/artikel...
|
|
V.SBM
|
In spite of the delay, when Sirona is able to close this deal (1067) the...
|
|
V.SBM
|
Could it be that the Sirona position is too big on your account and you are...
|
|
V.SBM
|
yes, and presumably existing investors have already enough...
|
|
V.SBM
|
Info for European Investors: Sirona has done the homework. Good! Pepole with...
|
|
V.SBM
|
You can see it in both way. Nobody is buying - no real news since long time...
|
|
V.SBM
|
In September/October we know whether Sirona is a success story or not. I...
|
|
V.SBM
|
Even if we have a deal today would you trust the management for any further...
|
|
V.SBM
|
check SEDAR: Sirona Biochem Receives TSX Venture Exchange Approval on...
|
|
V.SBM
|
As already said, what many do not have not on radar is how fast the “roll-out...
|
|
V.SBM
|
Sirona upload on 18. August 2016 the Information Circular (AGM) to Sedar. So...
|
|
V.SBM
|
I wrote that I do not much care about the value of the upfront and milestone...
|
|
V.SBM
|
To be clear. The figures only relate to the “Skin Care” product segment of...
|
|
V.SBM
|
All the delays are nerve-wracking. The small financial rounds annoying...
|
|
V.SBM
|
Did somebody an update (SGLT2, 1067, ...) from Sirona and/or Momentum PR...
|
|
V.SBM
|
Yes, this is the reason that the stock price is at 0.15. We are now at a...
|
|
C.CHX
|
Nice to see a new face here. The capital base is thin. I am expecting...
|
|
V.SBM
|
Next 1 -2 month will tell us - Truth or BS I am pretty sure we will see an...
|
|
V.SBM
|
A better than expected 2nd quarter earnings but the Skin Care segment...
|
|
V.SBM
|
A better than expected 2nd quarter earnings but the Skin Care divison...
|